期刊文献+
共找到2篇文章
< 1 >
每页显示 20 50 100
Identification of transition factors in myotube formation from proteome and transcriptome analyses
1
作者 ZHENG Qi HU Rong-cui +7 位作者 ZHU Cui-yun JING Jing LOU Meng-yu ZHANG Si-huan LI Shuang cao hong-guo ZHANG Xiao-rong LING Ying-hui 《Journal of Integrative Agriculture》 SCIE CAS CSCD 2023年第10期3135-3147,共13页
Muscle fibers are the main component of skeletal muscle and undergo maturation through the formation of myotubes.During early development,a population of skeletal muscle satellite cells(SSCs)proliferate into myoblasts... Muscle fibers are the main component of skeletal muscle and undergo maturation through the formation of myotubes.During early development,a population of skeletal muscle satellite cells(SSCs)proliferate into myoblasts.The myoblasts then undergo further differentiation and fusion events,leading to the development of myotubes.However,the mechanisms involved in the transition from SSCs to myotube formation remain unclear.In this study,we characterized changes in the proteomic and transcriptomic expression profiles of SSCs,myoblasts(differentiation for 2 d)and myotubes(differentiation for 10 d).Proteomic analysis identified SLMAP and STOM as potentially associated with myotube formation.In addition,some different changes in MyoD,MyoG,Myosin7 and Desmin occurred after silencing SLMAP and STOM,suggesting that they may affect changes in the myogenic marker.GO analysis indicated that the differentiation and migration factors SVIL,ENSCHIG00000026624(AQP1)and SERPINE1 enhanced the transition from SSCs to myoblasts,accompanied by changes in the apoptotic balance.In the myoblast vs.myotube group,candidates related to cell adhesion and signal transduction were highly expressed in the myotubes.Additionally,CCN2,TGFB1,MYL2 and MYL4 were identified as hub-candidates in this group.These data enhance our existing understanding of myotube formation during early development and repair. 展开更多
关键词 PROTEOME transcriptome skeletal muscle satellite cells MYOBLAST MYOTUBE
下载PDF
接骨续筋胶囊联合复方骨肽注射液治疗四肢骨折的临床研究 被引量:22
2
作者 曹洪国 刘跃华 陈岩 《现代药物与临床》 CAS 2019年第11期3347-3351,共5页
目的探讨接骨续筋胶囊联合复方骨肽注射液治疗四肢骨折的临床效果。方法选取2016年6月-2018年8月北京燕化医院收治的134例四肢骨折患者,随机分成对照组和治疗组,每组各67例。对照组静脉滴注复方骨肽注射液,10 mL加入250m L生理盐水均匀... 目的探讨接骨续筋胶囊联合复方骨肽注射液治疗四肢骨折的临床效果。方法选取2016年6月-2018年8月北京燕化医院收治的134例四肢骨折患者,随机分成对照组和治疗组,每组各67例。对照组静脉滴注复方骨肽注射液,10 mL加入250m L生理盐水均匀混合后给药,1次/d,连用3周后停药1周(此为1个周期),连用2个周期(共8周)。治疗组在对照组治疗基础上口服接骨续筋胶囊,4粒/次,3次/d。治疗8周后观察两组疗效。比较两组骨折临床愈合时间、相关症状评分、骨痂骨密度值和相关生长因子水平的变化。结果治疗后,对照组和治疗组的总有效率分别是85.1%、95.5%,两组比较差异具有统计学意义(P<0.05)。治疗后,两组疼痛评分、肿胀评分、瘀斑评分均显著降低,同组治疗前后比较差异有统计学意义(P<0.05);治疗后,治疗组这些症状评分显著低于对照组,两组比较差异有统计学意义(P<0.05)。治疗组肱骨干骨折临床愈合时间、尺桡骨干骨折临床愈合时间、股骨干骨折临床愈合时间、胫骨干骨折临床愈合时间均显著短于对照组,两组比较差异有统计学意义(P<0.05)。治疗后,两组血清转化生长因子(TGF)-β1、碱性成纤维生长因子(bFGF)、骨形态发生蛋白(BMP)-2水平均显著增加,同组治疗前后比较差异有统计学意义(P<0.05);治疗后,治疗组这些相关生长因子水平显著高于对照组,两组比较差异有统计学意义(P<0.05)。治疗组治疗4、8周时骨痂骨密度值均显著高于对照组,两组比较差异有统计学意义(P<0.05)。结论接骨续筋胶囊联合复方骨肽注射液治疗四肢骨折可明显减轻患者症状,缩短骨折愈合时间,增强骨折愈合强度,上调骨相关生长因子表达,具有一定的临床推广应用价值。 展开更多
关键词 接骨续筋胶囊 复方骨肽注射液 四肢骨折 转化生长因子-β1 碱性成纤维生长因子 骨形态发生蛋白-2
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部